Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals, Inc. | Curtis Rhyne | Virginia Foxx Member office · Republican-NC · 2008–2009 | Not stated | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Curtis Rhyne | Study Committee Committee · 2009–2014 | House Republican | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Curtis Rhyne | Richard Hudson Member office · Republican-NC · 2014–2017 | Not stated | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Curtis Rhyne | George Holding Member office · Republican-NC · 2017–2020 | Not stated | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Margaret Herman | Mark R. Warner Member office · Democrat-VA · 2017–2019 | Legislative Aide | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Margaret Herman | Mikie Sherrill Member office · Democrat-NJ · 2019–2020 | Legislative Assistant | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Margaret Herman | Daniel T. Kildee Member office · Democrat-MI · 2020–2022 | Senior LA | Alnylam Pharmaceuticals, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Amy Jensen | Office of the President Executive branch · 2003–2005 | Special Assistant to the President for Special Affairs | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sarah Egge | Bob Kerrey (Senate) Member office · Senate · 1998–2000 | Legislative Assistant | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sarah Egge | Senate Budget Committee Committee · 2001–2012 | Senior Budget Analyst for ( | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sarah Egge | Kent Conrad Member office · Democrat-ND · 2001–2012 | Senior Budget Analyst for ( | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sarah Egge | Joint Select Committee on Deficit Reduction Committee | Deputy Staff Director | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Paul Edattel | Commerce Committee Committee | Professional Staff Member for the Majority at the House Energy | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Paul Edattel | John Shadegg (House) Member office · House | Legislative Assistant & Legislative Director | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Katherine Cotton | Brett Guthrie Member office · Republican-KY | Staff Assistant, Legislative Correspondent, Legislative Assistant | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Eric Bergren | Brett Guthrie Member office · Republican-KY | Chief of Staff | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Eric Bergren | Ron Lewis (House) Member office · House | Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Eric Bergren | Bill Baker (House) Member office · House | Intern | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 9 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Nicolas Magallanes | Energy and Commerce Committee Committee | Policy Advisor/Professional Staff Member | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 4 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Nicolas Magallanes | Lee Terry Member office · Republican-NE | Policy Advisor/Professional Staff Member | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 4 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Nicolas Magallanes | Lamar Alexander Member office · Republican-TN | Legislative Correspondent/Legislative Aide | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 4 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Alanna Temme | Jon Porter (House) Member office · House | Legislative Director | LMH Strategic Solutions | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 8 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sophie Khanahmadi | Martha Roby Member office · Republican-AL | Legislative Asst | LMH Strategic Solutions | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sophie Khanahmadi | Lee Terry Member office · Republican-NE | Legislative Asst | LMH Strategic Solutions | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Sophie Khanahmadi | Jeff Sessions Member office · Republican-AL | Staff Asst./LC | LMH Strategic Solutions | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Daniel Todd | Senate Finance Committee Committee | Senior Health Counsel | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Daniel Todd | Office of Admin. Executive branch | Special Assistant, Ctr. - Medicare & Medicaid | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Ted Lehman | Senate Judiciary Committee Committee | Staff Assistant and Legislative Assistant | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Taylor Sexton | HHS Executive branch | Advisor to the Assistant Secretary of Legislation | Todd Strategy Group | Report period 2025 Q4 ↗ Posted Jan 21, 2026 · in 6 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Taylor Sexton | Michael C. Burgess Member office · Republican-TX | Health Care Policy Fellow | Todd Strategy Group | Report period 2025 Q4 ↗ Posted Jan 21, 2026 · in 6 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Jeff Lucas | Bill Cassidy Member office · Republican-LA | Health Policy Advisor | Todd Strategy Group | Report period 2025 Q3 ↗ Posted Oct 21, 2025 · in 5 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Jeff Lucas | Larry Bucshon Member office · Republican-IN | Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent | Todd Strategy Group | Report period 2025 Q3 ↗ Posted Oct 21, 2025 · in 5 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | John McManus | W&M Health Subcommittee Committee | Staff Director | The McManus Group | Report period 2025 Q3 ↗ Posted Oct 20, 2025 · in 4 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | John McManus | Bill Thomas (House) Member office · House | LA | The McManus Group | Report period 2025 Q3 ↗ Posted Oct 20, 2025 · in 4 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Kimberly Linthicum | Bob Franks (House) Member office · House | Legislative Director | Todd Strategy Group | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Kimberly Linthicum | Charles Taylor (House) Member office · House | Legislative Correspondent | Todd Strategy Group | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Kimberly Linthicum | Bill Martini (House) Member office · House | Legislative Correspondent | Todd Strategy Group | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 3 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Jeffrey Carroll | House Energy and Commerce Committee Committee | Staff Director | Capitol Counsel LLC | Report period 2025 Q1 ↗ Posted Mar 7, 2025 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Jeffrey Carroll | Frank Pallone, Jr. Member office · Democrat-NJ | Chief of Staff | Capitol Counsel LLC | Report period 2025 Q1 ↗ Posted Mar 7, 2025 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | John Martin | FDA Executive branch | Associate Commissioner | Capitol Counsel LLC | Report period 2025 Q1 ↗ Posted Mar 7, 2025 · in 2 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | John Martin | Tom Cotton Member office · Republican-AR | Legislative Assistant | Capitol Counsel LLC | Report period 2025 Q1 ↗ Posted Mar 7, 2025 · in 2 filings |
The newest 42 of 42 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 6:04 PM EST.